SNSS - Sunesis Pharmaceuticals EPS beats by $0.02 beats on revenue March, 10 2020 04:09 PM Viracta Therapeutics Inc Com Sunesis Pharmaceuticals (NASDAQ:SNSS): Q4 GAAP EPS of -$0.05 beats by $0.02.More news on: Sunesis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...